1. ALLA AKTIER
  2. NYHETER
  3. BONESUPPORT

Bonesupport

Nyheter Bonesupport Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Invitation to BONESUPPORT's Capital Markets Day

BONESUPPORT HOLDING AB (publ), a leader in orthobiologics for the management of bone injuries, will arrange a Capital Markets Day (CMD) for investors, analysts and the media on Tuesday, November 28, 2023, 13:30-17:00 pm CET.

The focus for the CMD is innovation and development within BONESUPPORT.
CEO Emil Billbäck and other members from the management team, as well as key opinion leaders (KOLs) in orthopedics, will be present.

The event will be held at the GT30 Grev Ture, room Bond, on Grev Turegatan 30 in Stockholm. To participate in person please register here:
https://financialhearings.com/event/48380/register/live_event.

The CMD will also be broadcast live on https://ir.financialhearings.com/bonesupport-cmd-2023/register. For online participation, pre-registration is not necessary. In addition, the event will be available on demand on the same link and on the BONESUPPORT's website.

For more information contact:

BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 329 million in 2022. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

Invitation to BONESUPPORT's Capital Markets Day

Datum 2023-11-17, kl 08:00
Källa MFN
Bifogade filer
Invitation to BONESUPPORT's Capital Markets Day